Multimodal Ultrasound in DBD Kidneys for Predicting Early Postoperative Renal Insufficiency Risk
NCT ID: NCT07090512
Last Updated: 2025-07-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
27 participants
OBSERVATIONAL
2025-01-01
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary question this study aims to address is:
Can multimodal ultrasound data from brain-dead organ donor kidneys accurately predict early post-transplant renal dysfunction?
Ultrasonography, as a routine examination before organ donation, will be utilized, and the study results will be concluded within one year after participation in this study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Kidney Disease and Ultrasound Imaging
NCT02201537
Pilot Study of Contrast-Enhanced Ultrasound of Transplanted Kidney
NCT01883583
Living Renal Donor MRI Study
NCT01280851
The Safety and Efficacy of Micro-energy Ultrasound in the Treatment of Renal Insufficiency After Renal Transplantation
NCT04119427
VisR Ultrasound for Noninvasively Monitoring Renal Allograft Health
NCT03079882
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multimodal Ultrasound
Multimodal ultrasound data collection will be conducted on all organ donors meeting the research criteria.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Underwent allogeneic kidney transplantation at this hospital;
Signed informed consent form.
Donor Study Participants Brain-deceased organ donors;
Completed organ donation at the First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital of Shandong Province);
Brain death criteria:
Deep coma (with clear etiology and exclusion of reversible causes);
Absence of brainstem reflexes;
No spontaneous respiration;
Confirmed by at least two confirmatory tests (SLSEP, EEG, TCD), with re-evaluation 12 hours after the initial determination.
Standard Criteria Donor (SCD):
* Age 10-39 years;
* Cause of death unrelated to cerebrovascular disease;
* Serum creatinine \<133 μmol/L;
* No history of hypertension.
Expanded Criteria Donor (ECD):
* Age \>60 years; OR
② Age 50-59 years with two of the following three criteria:
* Cause of death related to cerebrovascular disease;
* Serum creatinine \<133 μmol/L;
* History of hypertension.
Signed informed consent form.
Exclusion Criteria
Patients with follow-up duration less than 1 year;
Patients experiencing irreversible loss of graft function due to postoperative complications (e.g., rejection, thrombosis, anastomotic stenosis, infection).
Donor Study Participants Severe primary renal diseases (e.g., hypertensive nephropathy, diabetic nephropathy, renal tumors);
Cases with unavailable ultrasound imaging data:
Excessive respiratory motion in donors;
Obesity or other factors affecting imaging quality.
Individuals with allergic predisposition.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bei Wang
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bei Wang
Chief Physician
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The First Affiliated Hospital of Shandong First Medical University
Jinan, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
YXLL-KY-2024(172)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.